•   
  •   
  •   

Health & Fit Non-Oncology Drugs Surprisingly Capable Of Killing Cancer Cells

22:05  21 january  2020
22:05  21 january  2020 Source:   medicaldaily.com

Breast cancer survivors fight another deadly risk

  Breast cancer survivors fight another deadly risk Heart disease, not a recurrence of cancer, is the No. 1 cause of death for breast cancer survivors and women overall. More than 3.8 million breast cancer survivors live in the United States, and in about 10% of breast cancer patients, chemotherapy and radiation can damage the heart. It can happen during treatment, or the issue may develop years afterward, reports CBS News medical contributor Dr. Tara Narula, who is a cardiologist."It really did feel like another punch … where you've been punched a couple of times," Cianfrani said. "It was a little bit of a surprise especially because … I wasn't feeling anything.

A surprising effort to uncover drugs that might have useful medical applications other than the ones they were developed for has yielded welcome, and probably life-saving, results. One of the most welcome finds: drugs originally developed for diabetes, reducing inflammation, lowering cholesterol and alcoholism can also kill cancer cells in the lab.

This came about due to a study by scientists at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute, which led to the systematic analysis of thousands of drug compounds currently in use. The analysis found nearly 50 drugs with previously unrecognized anti-cancer activity. This totally unexpected find also revealed novel drug mechanisms and targets. The study also suggests this approach might be a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer.

Study: The secret of living to 110

  Study: The secret of living to 110 The secret to living past 100 could lie in your immune system, suggests a new study. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.getMedianetNativeAds(true); }); In a study recently published in Proceedings of the National Academy of Sciences (PNAS), scientists found that supercentenarians — those who are 110 years of age or older — have an overabundance of a certain type of disease-fighting cell within their immune systems, possibly explaining their longevity.

"We thought we'd be lucky if we found even a single compound with anti-cancer properties, but we were surprised to find so many," said Todd Golub, chief scientific officer and director of the Cancer Program at the Broad, Charles A. Dana Investigator in Human Cancer Genetics at Dana-Farber. Golub is also professor of pediatrics at Harvard Medical School.

The new study recently published in the peer-reviewed journal Nature Cancer is the largest yet to employ the Broad's Drug Repurposing Hub. This is a massive collection comprising more than 6,000 existing drugs and compounds either approved by the U.S. Food and Drug Administration (FDA), or proven safe in clinical trials.

The Hub contained 4,518 drugs at the time of the study. The study is also the first time researchers screened the entire collection of mostly non-cancer drugs for their anti-cancer capabilities. Researchers tested all the compounds in the Drug Repurposing Hub on 578 human cancer cell lines from the Broad's Cancer Cell Line Encyclopedia (CCLE).

South Carolina toddler survives rare cancer and the risky procedure used to treat it

  South Carolina toddler survives rare cancer and the risky procedure used to treat it A South Carolina family is giving thanks that their toddler survived a rare cancer and the dangerous procedure used to treat it.But as a blood test would later reveal, little Maci was actually suffering from an extremely rare blood cancer that threatened her life without a risky treatment - a treatment almost as dangerous as the disease.

After a battery of tests, researchers found nearly 50 non-cancer drugs that killed some cancer cells while leaving others alone. The study said some of the compounds killed cancer cells in totally unexpected ways.

"Most existing cancer drugs work by blocking proteins, but we're finding that compounds can act through other mechanisms," Steven Corsello, an oncologist at Dana-Farber, a member of the Golub lab and founder of the Drug Repurposing Hub, said.

Some of the nearly 50 non-cancer drugs Corsello and his colleagues identified appear to activate a protein or stabilize a protein-protein interaction and not by inhibiting a protein. According to Corsello, these unexpected drug mechanisms were easier to find using the study's cell-based approach that measures cell survival.

Most of the non-oncology drugs that killed cancer cells did so by interacting with a previously unrecognized molecular target. In one example, the anti-inflammatory drug tepoxalin (originally developed for use in people but later approved for treating osteoarthritis in dogs) killed cancer cells by hitting an unknown target in cells that overexpress the protein MDR1. It's this protein that commonly drives resistance to chemotherapy drugs.

15 Savory Shallot Recipes That Are Down-Right Delicious

  15 Savory Shallot Recipes That Are Down-Right Delicious We hand-picked these garden-fresh shallot recipes just for you! No harvesting required. The post 15 Savory Shallot Recipes That Are Down-Right Delicious appeared first on Taste of Home.

The team also found nearly a dozen non-oncology drugs killed cancer cells that express a protein called PDE3A. These drugs stabilize the interaction between PDE3A and another protein called SLFN12, which is a previously unknown mechanism for some of these drugs.

Related Video: FDA to Improve Access to Experimental Cancer Drugs (Provided by CBS News)


Scientists find powerhouses that fight tumors from within .
Lurking deep inside some tumors are "factories" full of immune cells that help the body fight a rearguard action against cancer and are key to helping some patients recover, new research shows. In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumors.

—   Share news in the SOC. Networks

Topical videos:

usr: 0
This is interesting!